A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION). Article

Kotecha, Rupesh, Odia, Yazmin, Chen, Zhijian et al. (2024). A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION). . JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), tps2093-tps2093. 10.1200/jco.2024.42.16_suppl.tps2093

cited authors

  • Kotecha, Rupesh; Odia, Yazmin; Chen, Zhijian; Starosciak, Amy K; Rubens, Muni; La Rosa, Alonso; Herrera, Susana; Ramirez Menendez, Miguel A; Pow-Sang, Cristina I; Ramos, Suyen; Perez, Jennifer; Ahluwalia, Manmeet Singh; Mehta, Minesh P

authors

publication date

  • June 1, 2024

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • 6.5 Radiotherapy and other non-invasive therapies
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Health Disparities
  • Minority Health
  • Neurosciences
  • Orphan Drug
  • Patient Safety
  • Radiation Oncology
  • Rare Diseases

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • tps2093

end page

  • tps2093

volume

  • 42

issue

  • 16_suppl